What WBC defines high-risk APL?

WBC above 10,000/mm3 at diagnosis defines high-risk APL with increased differentiation syndrome (DS) risk. DS can occur in low-risk APL too (15–25% of cases). Prophylactic dexamethasone 10 mg IV BID starting on day 1 of ATRA is recommended for all APL regardless of WBC.

What are the features of APL differentiation syndrome?

DS criteria: 3 or more of: fever, dyspnea, weight gain above 5 kg, pulmonary infiltrates, pleural or pericardial effusion, hypotension, or renal failure. Mild-moderate DS: continue ATRA with dexamethasone. Severe DS: hold ATRA, add arsenic trioxide if available.

APL White Count Differentiation Syndrome Risk

Assess acute promyelocytic leukemia differentiation syndrome risk based on presenting white blood cell count, with prophylactic dexamethasone protocol for high-risk presentations (WBC above 10K).

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.

How It Works

Assess acute promyelocytic leukemia differentiation syndrome risk based on presenting white blood cell count, with prophylactic dexamethasone protocol for high-risk presentations (WBC above 10K)

Each component has a specific meaning:

Presenting white blood cell count — The presenting white blood cell count recorded for the scenario being assessed.

Note: Interpret the apl ds risk result against the thresholds and context described above.

How to Use

Enter the presenting white blood cell count for the scenario you are assessing. Assess acute promyelocytic leukemia differentiation syndrome risk based on presenting white blood cell count, with prophylactic dexamethasone protocol for high-risk presentations (WBC above 10K). Use the apl ds risk result to inform your calculation.

Related Calculators

AML ELN 2022

Medical Long-tail

AML Blast Threshold